11/24/2025
For cancer clinicians, developments in therapeutic cancer vaccines and preventive vaccines represent a shift toward precision immunotherapy that could complement existing treatment protocols, Mayo Clinic describes.
"50 years ago, we didn't have the capabilities we have now," Dr. Knutson expresses. "Our capabilities are rapidly changing and accumulating. Over the next 20 years, we're going to see some great improvements in how we use vaccines to activate the immune system to suppress cancer development, treat cancer and prevent it from coming back." Read more during Lung Cancer Awareness Month: https://mayocl.in/4ougtLx
Researchers at Mayo Clinic are studying vaccines that target HER2 and MUC1, which are overexpressed in many cancers, such as lung cancer. These advances aim to prevent, treat and reduce recurrence.